Mr. McClellan, who was appointed to finance chief in 2017, reportedly is leaving the company for personal reasons that require him to be close to his family.
The departure comes as Teva works on a turnaround to improve its finances. This week the generic drugmaker reported a net loss of $698 million in the second quarter of 2019.
The drugmaker will be searching for a new finance chief amid high company debt levels, opioid litigation and a price-fixing investigation.
More articles on pharmacy:
2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
